Kineticos Disruptor — Full Portfolio
2 tracked investments · listed companies and verified rows first
Inceptor Bio is a clinical-stage biotechnology company developing cell therapies for cancer, focused on solid tumors.
BiotechHealthtechMorrisville, US
Jason Lawrence(Executive Officer)inMatthias Schroff(Executive Officer, Director)inAbraham S. Maingi(Executive Officer)Shailesh Maingi(Director)inDavid Michael Johnston(Director)
BoardMark Bamforth(Director)in
Board seatShailesh Maingi· per SEC Form D · $3.4M raise · filed Jan 2025
Orthobond develops proprietary antimicrobial nanosurface technology that covalently binds to metallic and polymeric surfaces to mechanically kill bacteria, viruses, and fungi without antibiotics or eluting chemicals.
HealthtechMedical DevicesNew MaterialsMonmouth Junction, US
David Nichols(CEO)inPeter Goodwin(Director)Frank Cammisa(Director)Khalil Barrage(Director)Lisa D'Urso(Director)David Helfet(Director)
Board seatShailesh Maingi· per SEC Form D · $10M raise · filed Sep 2026
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.